A detailed history of Ferguson Wellman Capital Management, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Ferguson Wellman Capital Management, Inc holds 20,820 shares of LLY stock, worth $17.6 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
20,820
Previous 20,974 0.73%
Holding current value
$17.6 Million
Previous $18.6 Million 13.5%
% of portfolio
0.32%
Previous 0.37%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

SELL
$727.2 - $932.06 $111,988 - $143,537
-154 Reduced 0.73%
20,820 $16.1 Million
Q3 2024

Nov 06, 2024

BUY
$772.14 - $960.02 $478,726 - $595,212
620 Added 3.05%
20,974 $18.6 Million
Q3 2024

Oct 18, 2024

SELL
$772.14 - $960.02 $809,202 - $1.01 Million
-1,048 Reduced 4.9%
20,354 $18 Million
Q2 2024

Jul 16, 2024

SELL
$724.87 - $909.04 $186,291 - $233,623
-257 Reduced 1.19%
21,402 $19.4 Million
Q1 2024

Apr 09, 2024

SELL
$592.2 - $792.28 $23,095 - $30,898
-39 Reduced 0.18%
21,659 $16.8 Million
Q4 2023

Jan 11, 2024

SELL
$525.19 - $619.13 $337,697 - $398,100
-643 Reduced 2.88%
21,698 $12.6 Million
Q3 2023

Oct 12, 2023

BUY
$434.7 - $599.3 $30,863 - $42,550
71 Added 0.32%
22,341 $12 Million
Q2 2023

Jul 11, 2023

SELL
$350.74 - $468.98 $45,245 - $60,498
-129 Reduced 0.58%
22,270 $10.4 Million
Q1 2023

Apr 20, 2023

SELL
$310.63 - $364.82 $123,009 - $144,468
-396 Reduced 1.74%
22,399 $7.69 Million
Q4 2022

Jan 13, 2023

BUY
$321.55 - $374.67 $2.12 Million - $2.47 Million
6,600 Added 40.75%
22,795 $8.34 Million
Q3 2022

Oct 17, 2022

SELL
$296.48 - $337.87 $1.21 Million - $1.38 Million
-4,081 Reduced 20.13%
16,195 $5.24 Million
Q2 2022

Jul 14, 2022

BUY
$278.73 - $327.27 $23,692 - $27,817
85 Added 0.42%
20,276 $6.57 Million
Q1 2022

Apr 14, 2022

SELL
$234.69 - $291.66 $19,948 - $24,791
-85 Reduced 0.42%
20,191 $5.78 Million
Q4 2021

Jan 10, 2022

SELL
$224.85 - $279.04 $67,455 - $83,712
-300 Reduced 1.46%
20,276 $5.6 Million
Q3 2021

Oct 22, 2021

SELL
$221.6 - $272.71 $33,018 - $40,633
-149 Reduced 0.72%
20,576 $4.75 Million
Q2 2021

Jul 12, 2021

SELL
$180.55 - $233.54 $56,692 - $73,331
-314 Reduced 1.49%
20,725 $4.76 Million
Q1 2021

Apr 26, 2021

SELL
$164.32 - $212.72 $960,943 - $1.24 Million
-5,848 Reduced 21.75%
21,039 $3.93 Million
Q4 2020

Feb 04, 2021

SELL
$130.46 - $172.63 $171,685 - $227,181
-1,316 Reduced 4.67%
26,887 $4.54 Million
Q3 2020

Oct 13, 2020

SELL
$146.22 - $169.13 $130,135 - $150,525
-890 Reduced 3.06%
28,203 $4.18 Million
Q2 2020

Aug 04, 2020

SELL
$136.42 - $164.18 $300,124 - $361,196
-2,200 Reduced 7.03%
29,093 $4.78 Million
Q1 2020

Apr 21, 2020

SELL
$119.05 - $147.35 $408,460 - $505,557
-3,431 Reduced 9.88%
31,293 $4.34 Million
Q4 2019

Jan 24, 2020

SELL
$106.92 - $132.43 $247,626 - $306,707
-2,316 Reduced 6.25%
34,724 $4.56 Million
Q3 2019

Oct 15, 2019

SELL
$106.79 - $116.16 $20 Million - $21.7 Million
-187,235 Reduced 83.48%
37,040 $4.14 Million
Q2 2019

Jul 16, 2019

SELL
$110.79 - $129.32 $4.46 Million - $5.21 Million
-40,285 Reduced 15.23%
224,275 $24.8 Million
Q1 2019

Apr 11, 2019

SELL
$111.31 - $131.02 $14.3 Million - $16.8 Million
-128,479 Reduced 32.69%
264,560 $34.3 Million
Q4 2018

Jan 16, 2019

SELL
$105.9 - $118.64 $10.8 Million - $12.1 Million
-101,698 Reduced 20.56%
393,039 $45.5 Million
Q3 2018

Oct 25, 2018

BUY
$85.86 - $107.31 $15.4 Million - $19.3 Million
179,671 Added 57.03%
494,737 $53.1 Million
Q2 2018

Aug 10, 2018

BUY
$75.7 - $86.88 $5.02 Million - $5.76 Million
66,307 Added 26.66%
315,066 $26.9 Million
Q1 2018

Apr 09, 2018

BUY
$74.21 - $87.6 $16.3 Million - $19.2 Million
219,468 Added 749.27%
248,759 $19.2 Million
Q4 2017

Jan 24, 2018

SELL
$81.94 - $87.89 $91,526 - $98,173
-1,117 Reduced 3.67%
29,291 $2.47 Million
Q3 2017

Oct 11, 2017

BUY
$77.07 - $85.54 $2.34 Million - $2.6 Million
30,408
30,408 $2.6 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $802B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ferguson Wellman Capital Management, Inc Portfolio

Follow Ferguson Wellman Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ferguson Wellman Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ferguson Wellman Capital Management, Inc with notifications on news.